ADENIUM BIOTECH ApS
CVR 33882785 · Private limited company (ApS) · Dissolved after voluntary liquidation
ADENIUM BIOTECH ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling indenfor bioteknologi. The company is no longer active (status: dissolved after voluntary liquidation). 9 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2018) shows equity of DKK 1.9m and a net result of DKK -4.6m.
Company details
- CVR number
- 33882785
- Status
- Dissolved after voluntary liquidation
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 3.8m
- Employees
- 2 (2018)
- Auditor
- Ernst & Young Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 26.4% |
| Current ratio | 135% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2018 | 2017 |
|---|---|---|
| Net profit | DKK -4.6m | DKK -12.5m |
| Equity | DKK 1.9m | DKK 6.5m |
| Total assets | DKK 7.3m | DKK 8.2m |
| Cash | DKK 6.3m | – |
| Short-term debt | DKK 5.4m | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Ernst & Young Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2019 – 31 Dec 2019 | 148 | ||
| 1 Jan 2018 – 31 Dec 2018 | 177 | ||
| 1 Jan 2017 – 31 Dec 2017 | 155 | ||
| 1 Jan 2016 – 31 Dec 2016 | 153 | ||
| 1 Jan 2015 – 31 Dec 2015 | 190 | Late | |
| 1 Jan 2014 – 31 Dec 2014 | 155 | ||
| 1 Jan 2013 – 31 Dec 2013 | 126 | ||
| 1 Jan 2012 – 31 Dec 2012 | 133 | ||
| 2 Sep 2011 – 31 Dec 2011 | 110 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Hviid Nordkild | ||
| CEO | Torgeir Vaage | ||
| Board | Peter Hviid Nordkild | ||
| Board | Kristian Merser | ||
| Board | Anker Gunvald Lundemose | ||
| Board | Casper Tind Hansen | ||
| Board | Ejner Bech Jensen | ||
| Board | Andreas Rutger Segerros | ||
| Board | Stephan Christgau | ||
| Board | Khalid Islam | ||
| Board | Paul David Goldenheim | ||
| Board | Paul David Goldenheim | ||
| Board | Paul David Goldenheim | ||
| Board | John Howard Rex | ||
| Board | Joseph Michael Feczko | ||
| Board | Emmanuelle Coutanceau | ||
| Board | James Peter Arthur Benson | ||
| Owner (50%) | Novo Holdings A/S | ||
| Owner (33%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (33%) | Novo Holdings A/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Auditor | 18. juni 2024 P/S | ||
| Founder | Novo Holdings A/S |
The CEOs' other companies
Peter Hviid Nordkild – 13 other companies, of which 2 bankrupt
- PATIENTLINK A/S Bankrupt 29 Oct 2008
- SG PARTNER A/S Bankrupt 26 Jul 2001
- ARTS BIOLOGICS A/S Opløst
- Aesculus Bio ApS Active
- Asarina Pharma ApS Opløst
- BIOPORTO A/S Active
- DEFENSIN THERAPEUTICS ApS Active
- GN RESOUND DANMARK A/S Fusioneret
- KOMPLEMENTARSELSKABET LANGE STRASSE, DELMENHORST ApS Opløst
- ORACAIN II ApS Opløst
- PN INVESTMENT ApS Active
- PONTICULUS G.m.b.H. ApS Active
- SUNDHEDSGUIDEN MEDIA ApS Active
Address history (2 moves)
| Ole Maaløes Vej 3, 2200 København N | |
| c/o COBIS, Ole Maaløes Vej 3, 2200 København N | |
| c/o Novo A/S, Tuborg Havnevej 19, 2900 Hellerup |
Employees per year
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about ADENIUM BIOTECH ApS
Has ADENIUM BIOTECH ApS gone bankrupt?
No, ADENIUM BIOTECH ApS is not registered as bankrupt in the CVR register. Its status is: dissolved after voluntary liquidation.
Who is the auditor of ADENIUM BIOTECH ApS?
ADENIUM BIOTECH ApS most recently used Ernst & Young Godkendt Revisionspartnerselskab.
When was ADENIUM BIOTECH ApS founded?
ADENIUM BIOTECH ApS was founded on 2 September 2011.
What is the equity of ADENIUM BIOTECH ApS?
Equity was DKK 1.9m according to the annual report for the period ending 31 December 2018.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.